Conference Archive
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
LEVEL UP Study Shows Benefits of Switching From Dupilumab to Upadacitinib in AD
4
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
5